Filing Flows

Filing Flows › Baxter International (BAX) › Q3 2026

Baxter International (BAX) Q3 2026 earnings results (third quarter 2026)

10-Q filed Oct 29, 2026

Baxter International (BAX) reported revenue of $3.0B for the third quarter 2026 (Q3 2026), +5% from a year earlier and +0.5% from the quarter before. Operating margin was 7.6%, net earnings $294M (9.9% of revenue).

Revenue$3.0B
Year over year+5%
Quarter over quarter+0.5%
Operating margin7.6%
Net earnings$294M

Baxter International, Q3 2026: revenue $3.0B (+5% year over year), operating margin 7.6%, net earnings $294M, operating cash flow $558M. The chart follows the revenue to costs, profit and cash.

Q3 2026AmountQ/QY/Y
Revenue$3.0B+0.5%+5%
Gross profit$994M-4%+5%
Operating profit$225M+4%+31%
Net earnings$294M+133%—
Operating cash flow$558M+96%+135%
Free cash flow$448M—+256%

What changed

Revenue was $3.0B in Q3 2026, up 5% year over year and up 1% from the previous quarter.

Gross margin was 33.4%, down 0.1 points from Q3 2025. Operating profit was $0.23B, a 7.6% margin (up 1.5 points year over year). Of the extra revenue versus Q3 2025, 38% reached operating profit, above the 6% margin then. Operating expenses fell 1% while revenue rose 5%. Net earnings were $0.29B. The effective tax rate was 28.8%. Non-operating items added $0.19B, 46% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $0.56B (up 135% year over year), 190% of net earnings. Non-cash charges added back $0.24B of depreciation and amortization and $0.03B of share-based compensation. Capital expenditures of $0.11B left free cash flow of $0.45B.

Questions

What was Baxter International's revenue in the third quarter 2026?

Baxter International (BAX) reported revenue of $3.0B for the third quarter 2026 (Q3 2026), +5% from a year earlier and +0.5% from the quarter before.

Was Baxter International profitable in the third quarter 2026?

Operating profit was $225M (7.6% of revenue) and net earnings $294M.

Open the interactive Sankey →

Source: Baxter International 10-Q on SEC EDGAR.